Who
Timothy August Durso
Chief Technical Officer
Company insider
Files Form 4 as: Chief Technical Officer, Veradermics.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $9.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Feb 2026
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Code M | $42K3,452 at $12.19 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $845K7,918 at $106.71 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $1.8M16,306 at $107.52 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,452 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $1.8M16,767 at $108.38 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $257K2,348 at $109.34 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $18K161 at $111.28 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,452 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Code M | $42K3,452 at $12.19 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $845K7,918 at $106.71 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $1.8M16,306 at $107.52 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $1.8M16,767 at $108.38 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $257K2,348 at $109.34 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $18K161 at $111.28 | filing |
| 5 Feb 2026filed 5 Feb 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Code C | —1,473 | filing |
| 5 Feb 2026filed 5 Feb 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,473 | filing |
| 5 Feb 2026filed 5 Feb 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,473 | filing |
| 5 Feb 2026filed 5 Feb 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Code C | —1,473 | filing |
| 3 Feb 2026filed 5 Feb 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —213,352 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —213,352 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.